Ticker: CRSP

Cathie Wood's ARK Innovation ETF is eyeing biotech stocks CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA). CRISPR's stock is down 13% this year, with a promising gene-therapy product yet to deliver revenue. Intellia, down 27%, targets rare diseases but faces financial ...